MicroRNA-24 Regulates Vascularity After Myocardial Infarction

作者:Fiedler Jan; Jazbutyte Virginija; Kirchmaier Bettina C; Gupta Shashi K; Lorenzen Johan; Hartmann Dorothee; Galuppo Paolo; Kneitz Susanne; Pena John T G; Sohn Lee Cherin; Loyer Xavier; Soutschek Juergen; Brand Thomas; Tuschl Thomas; Heineke Joerg; Martin Ulrich; Schulte Merker Stefan; Ertl Georg; Engelhardt Stefan; Bauersachs Johann; Thum Thomas*
来源:Circulation, 2011, 124(6): 720-U178.
DOI:10.1161/CIRCULATIONAHA.111.039008

摘要

Background-Myocardial infarction leads to cardiac remodeling and development of heart failure. Insufficient myocardial capillary density after myocardial infarction has been identified as a critical event in this process, although the underlying mechanisms of cardiac angiogenesis are mechanistically not well understood. Methods and Results-Here, we show that the small noncoding RNA microRNA-24 (miR-24) is enriched in cardiac endothelial cells and considerably upregulated after cardiac ischemia. MiR-24 induces endothelial cell apoptosis, abolishes endothelial capillary network formation on Matrigel, and inhibits cell sprouting from endothelial spheroids. These effects are mediated through targeting of the endothelium-enriched transcription factor GATA2 and the p21-activated kinase PAK4, which were identified by bioinformatic predictions and validated by luciferase gene reporter assays. Respective downstream signaling cascades involving phosphorylated BAD (Bcl-XL/Bcl-2-associated death promoter) and Sirtuin1 were identified by transcriptome, protein arrays, and chromatin immunoprecipitation analyses. Overexpression of miR-24 or silencing of its targets significantly impaired angiogenesis in zebrafish embryos. Blocking of endothelial miR-24 limited myocardial infarct size of mice via prevention of endothelial apoptosis and enhancement of vascularity, which led to preserved cardiac function and survival. Conclusions-Our findings indicate that miR-24 acts as a critical regulator of endothelial cell apoptosis and angiogenesis and is suitable for therapeutic intervention in the setting of ischemic heart disease. (Circulation. 2011; 124: 720-730.)

  • 出版日期2011-8-9